List of BSU publications about our research on COVID-19, organised by research area 

---

Providing evidence on the course of the epidemic on COVID-19

Birrell P et al. Real-time Nowcasting and Forecasting of COVID-19 Dynamics in England: the first wave? medRxiv preprint doi: https://doi.org/10.1101/2020.08.24.20180737

Illingworth C et al. Superspreaders drive the largest outbreaks of hospital onset COVID-19 infection. preprint doi: 10.31219/osf.io/wmkn3

Illingworth C et al. A2B-COVID: A method for evaluating potential SARS-CoV-2 transmission events. medRxiv preprint doi: https://doi.org/10.1101/2020.10.26.20219642

Kemp SA et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021 Feb 5. doi: 10.1038/s41586-021-03291-y. Online ahead of print. PMID: 33545711

Pouwels KB et al. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health. 2020 Dec 10:S2468-2667(20)30282-6. doi: 10.1016/S2468-2667(20)30282-6. Online ahead of print. PMID: 33308423 

Seaman S et al. Nowcasting CoVID-19 Deaths in England by Age and Region. medRxiv preprint doi: https://doi.org/10.1101/2020.09.15.20194209

Simpson CR et al. The UK hibernated pandemic influenza research portfolio: triggered for COVID-19. Lancet Infect Dis. 2020 Jul;20(7):767-769. doi: 10.1016/S1473-3099(20)30398-4. Epub 2020 May 15. PMID: 32422199

Wiegand M et al. Development and validation of a dynamic 48-hour in-hospital prognostic risk stratification for COVID-19 in a UK teaching hospital: a retrospective cohort study. medRxiv preprint doi: https://doi.org/10.1101/2021.02.15.21251150

---

Providing evidence for patient care

Bergamaschi L et al. Early immune pathology and persistent dysregulation characterise severe COVID-19. medRxiv preprint doi: https://doi.org/10.1101/2021.01.11.20248765

Burgess S et al. Lightening the viral load to lessen covid-19 severity. BMJ. 2020 Dec 10;371:m4763. doi: 10.1136/bmj.m4763. PMID: 33303483 

Burgess S et al. Rising numbers of positive covid-19 tests in the UK. BMJ. 2020. 370:m3605. PMID:32943434

Burgess S et al. Are we underestimating seroprevalence of SARS-CoV-2?. BMJ. 2020. 370:m3364. PMID:32883673

Gisby J et al. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals
2 markers of severity and predictors of death. medRxiv preprint: doi:https://doi.org/10.1101/2020.11.05.20223289

Larsson SC et al. Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia. Eur Respir J. 2020 Nov 19:2003545. doi: 10.1183/13993003.03545-2020. Online ahead of print. PMID: 33214204 

Ponsford MJ et al. Cardiometabolic Traits, Sepsis and Severe COVID-19: A Mendelian Randomization Investigation. Circulation. 2020. PMID:32966752

---

Designing and analysing interventions on care for COVID-19 patients

Cao B et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. PMID: 32187464

Cunniffe NG et al. How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis. BMJ Open. 2020. 10:e044566. PMID:33020111

Dodd LE et al. Endpoints for randomized controlled clinical trials for COVID-19 treatments. Clin Trials. 2020 Oct;17(5):472-482. doi: 10.1177/1740774520939938. Epub 2020 Jul 16. PMID: 32674594

Griffiths G et al. AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial. Trials. 2020 Jun 19;21(1):544. doi: 10.1186/s13063-020-04473-1. PMID: 32560744

RECOVERY Collaborative Group. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Oct 8. doi: 10.1056/NEJMoa2022926. Online ahead of print. PMID: 33031652

RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020 Oct 5:S0140-6736(20)32013-4. doi: 10.1016/S0140-6736(20)32013-4. Online ahead of print. PMID: 33031764

RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report. N Engl J Med. 2020 Jul 17:NEJMoa2021436. doi: 10.1056/NEJMoa2021436. Online ahead of print. PMID: 32678530

Wang Y et al. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9. PMID: 32448345 

Wang Y et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. PMID: 32423584

Witham MD et al. Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project. BMJ Open. 2020 Nov 5;10(11):e043634. doi: 10.1136/bmjopen-2020-043634. PMID: 33154065 

---

Lay Articles

Sylvia Richardson. Vaccine rollouts, school testing and contact tracing could all be improved – here’s how. 5 Feb 2021. The Conversation.

Co-authors include Sylvia Richardson. Covid-19 INNOVA testing in schools: don’t just test, evaluate. BMJ Opinion Piece.

Peter J. Diggle and Sylvia Richardson. A perspective on real-time epidemic surveillance for Covid-19. 29 Sept 2020. Significance magazine.

Sylvia Richardson and David Spiegelhalter. Coronavirus statistics: what can we trust and what should we ignore? 12 Apr 2020. The Observer.

---

News

Read our COVID-19 news articles and listen to podcasts which members of our Unit have taken part in – COVID-19 News